Dhingra Kapil
- SEC CIK
- 0001456849
In the past year, 1 open-market sale filing worth $33.0K and no purchases.
Current role at each company
- BDTX Black Diamond Therapeutics, Inc.Directoras of Jun 29, 2026
- REPL Replimune Group, Inc.Directoras of Apr 7, 2026
- LVTX LAVA Therapeutics NVDirectoras of Nov 17, 2025
- CRGX CARGO Therapeutics, Inc.Directoras of Aug 19, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $33.0K
- 1 filing
- Net
- −$33.0K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Dhingra Kapil as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
REPL Replimune Group, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 11, 2025 (view filing) | Dec 9 | 2 days | Dhingra KapilDirector | SSale | −3.17K | $10.40 | −$33.0K | −100.0%0 after |